IFP Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.54M | Sell |
12,005
-467
| -4% | -$91.7K | 0.05% | 419 |
|
|
2026
Q1 | $2.44M | Sell |
12,472
-3,792
| -23% | -$737K | 0.05% | 390 |
|
|
2025
Q4 | $2.82M | Buy |
16,264
+3,986
| +32% | +$726K | 0.06% | 334 |
|
|
2025
Q3 | $2.34M | Buy |
12,278
+30
| +0.2% | +$5.32K | 0.06% | 340 |
|
|
2025
Q2 | $2.22M | Sell |
12,248
-1,194
| -9% | -$207K | 0.06% | 333 |
|
|
2025
Q1 | $2.36M | Sell |
13,442
-2,081
| -13% | -$342K | 0.07% | 321 |
|
|
2024
Q4 | $2.35M | Buy |
15,523
+14,579
| +1,544% | +$2.27M | 0.08% | 294 |
|
|
2024
Q3 | $147K | Sell |
944
-56
| -6% | -$8.36K | 0.01% | 1238 |
|
|
2024
Q2 | $137K | Sell |
1,000
-19
| -2% | -$2.6K | 0.01% | 1221 |
|
|
2024
Q1 | $136K | Buy |
1,019
+19
| +2% | +$2.46K | 0.01% | 1170 |
|
|
2023
Q4 | $138K | Sell |
1,000
-423
| -30% | -$55.6K | 0.01% | 1127 |
|
|
2023
Q3 | $173K | Sell |
1,423
-31
| -2% | -$4.13K | 0.01% | 1029 |
|
|
2023
Q2 | $204K | Sell |
1,454
-517
| -26% | -$71.3K | 0.01% | 1014 |
|
|
2023
Q1 | $115K | Sell |
1,971
-1,198
| -38% | -$171K | 0.01% | 1184 |
|
|
2022
Q4 | $238K | Sell |
3,169
-623
| -16% | -$89.5K | 0.01% | 1265 |
|
|
2022
Q3 | $254K | Buy |
3,792
+98
| +3% | +$12.9K | 0.01% | 1276 |
|
|
2022
Q2 | $248K | Hold |
3,694
| – | – | 0.01% | 1171 |
|
|
2022
Q1 | $248K | Buy |
3,694
+2,963
| +405% | +$413K | 0.01% | 1171 |
|
|
2021
Q4 | $128K | Buy |
731
+61
| +9% | +$9.28K | ﹤0.01% | 1159 |
|
|
2021
Q3 | $98K | Sell |
670
-557
| -45% | -$81.5K | ﹤0.01% | 1306 |
|
|
2021
Q2 | $161K | Buy |
1,227
+137
| +13% | +$17.9K | ﹤0.01% | 1018 |
|
|
2021
Q1 | $139K | Sell |
1,090
-48
| -4% | -$5.92K | ﹤0.01% | 1004 |
|
|
2020
Q4 | $135K | Buy |
1,138
+65
| +6% | +$7.92K | 0.01% | 984 |
|
|
2020
Q3 | $123K | Buy |
1,073
+292
| +37% | +$34.5K | 0.01% | 898 |
|
|
2020
Q2 | $85K | Buy |
781
+429
| +122% | +$45.5K | 0.01% | 984 |
|
|
2020
Q1 | $32K | Buy |
352
+90
| +34% | +$9.32K | ﹤0.01% | 1304 |
|
|
2019
Q4 | $27K | Buy |
262
+126
| +93% | +$13.1K | ﹤0.01% | 1493 |
|
|
2019
Q3 | $13K | Buy |
+136
| New | +$14K | ﹤0.01% | 1947 |
|
|
2019
Q1 | $25K | Sell |
278
-1,905
| -87% | -$165K | ﹤0.01% | 1247 |
|
|
2018
Q4 | $179K | Sell |
2,183
-517
| -19% | -$48.5K | 0.01% | 914 |
|
|
2018
Q3 | $291K | Sell |
2,700
-1,691
| -39% | -$185K | 0.01% | 898 |
|
|
2018
Q2 | $483K | Buy |
4,391
+1,758
| +67% | +$183K | 0.02% | 669 |
|
|
2018
Q1 | $259K | Hold |
2,633
| – | – | 0.01% | 882 |
|
|
2017
Q4 | $259K | Sell |
2,633
-252
| -9% | -$23.9K | 0.01% | 883 |
|
|
2017
Q3 | $270K | Sell |
2,885
-402
| -12% | -$42.7K | 0.01% | 969 |
|
|
2017
Q2 | $365K | Buy |
3,287
+351
| +12% | +$37.1K | 0.02% | 815 |
|
|
2017
Q1 | $288K | Buy |
2,936
+407
| +16% | +$38.8K | 0.01% | 922 |
|
|
2016
Q4 | $232K | Buy |
2,529
+1,548
| +158% | +$133K | 0.01% | 980 |
|
|
2016
Q3 | $83K | Buy |
981
+10
| +1% | +$840 | ﹤0.01% | 1484 |
|
|
2016
Q2 | $79K | Buy |
971
+693
| +249% | +$52.8K | ﹤0.01% | 1477 |
|
|
2016
Q1 | $25K | Sell |
278
-435
| -61% | -$29.2K | ﹤0.01% | 1246 |
|
|
2015
Q4 | $51K | Buy |
+713
| New | +$47.9K | ﹤0.01% | 1612 |
|
Other funds holding DGX
EIG
IFP Advisors's DGX Position: Q2 2026 in Review
IFP Advisors reduced its Quest Diagnostics (DGX) stake by 3.7% in Q2 2026, selling an estimated $91.7K and leaving 12,005 shares worth $2.54M. The position accounts for 0.05% of the portfolio, ranked #419.
IFP Advisors first reported a position in DGX in Q4 2015 and has held it in 42 quarters since. The position peaked at $2.82M in Q4 2025. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- IFP Advisors held 12,005 shares of Quest Diagnostics worth $2.54M as of Q2 2026.
- IFP Advisors sold 467 Quest Diagnostics shares in Q2 2026, an estimated $91.7K.
- Quest Diagnostics made up 0.05% of IFP Advisors's portfolio in Q2 2026, its #419 holding.
- IFP Advisors first reported a position in Quest Diagnostics in Q4 2015 and has held it in 42 quarters since.
- IFP Advisors's Quest Diagnostics position peaked at $2.82M in Q4 2025.
- 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.